Sana Biotechnology Inc vs Symbotic Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Symbotic Inc trades at $43.33 (market cap $5.19B). The key difference: Symbotic Inc is far larger — about 5.9× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | SYM | |
|---|---|---|
Market Cap | $873.84M | $5.19B |
Sector | Health | Technology |
52-Week High | $5.92 | $87.30 |
52-Week Low | $2.68 | $38.57 |
Enterprise Value | $848.03M | $3.18B |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →